Topics

Avelumab Falls Short as Frontline Maintenance for Gastric/GEJ Cancer

15:42 EST 8 Nov 2019 | OncLive

Avelumab did not improve overall survival as frontline maintenance following induction chemotherapy in patients with unresectable, locally advanced, or metastatic HER2-negative gastric or gastroesophageal junction cancer.

Original Article: Avelumab Falls Short as Frontline Maintenance for Gastric/GEJ Cancer

NEXT ARTICLE

More From BioPortfolio on "Avelumab Falls Short as Frontline Maintenance for Gastric/GEJ Cancer"

Quick Search

Relevant Topic

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...